Treatment for decreased libido in women begins with understanding why desire has decreased and how this change affects the woman's life. There is no single frequency of sexual intercourse, no single hormone target, or no medication that works for everyone. The assessment takes into account physical health, mental state, medications used, lifestyle, and the nature of the relationship. The goal is not to meet someone else's expectations, but to enable the individual to have a more comfortable and satisfying sexual life according to their own desires. The NHS's low libido information also emphasizes that treatment is chosen according to the underlying cause.
Two people seeking help for decreased libido may have very different needs. One might be experiencing postpartum insomnia and dryness, while the other might be dealing with painful intercourse or a newly started medication. Therefore, focusing solely on a "libido-enhancing" product can make it difficult to see the root cause. The initial consultation will clarify what has changed, when it changed, and what kind of support the individual needs. You don't have to share all the details in a single session; the boundaries of the conversation and the assessment steps can be determined together.
Changes in sexual desire from time to time do not, in themselves, indicate a disorder. Similarly, differences in desire between partners do not automatically suggest a disorder in the person with less desire. The important factors in assessment are the individual's own distress, the persistence of the change, and whether it can be explained by other causes. ACOG states that in some individuals, sexual desire may emerge after intimacy has begun. This does not mean that the person should engage in unwanted contact; mutual consent and the freedom to stop are essential at every stage.
Instead of asking yourself, "Am I normal?", asking yourself, "Does this situation bother me? Under what circumstances does it change? What do I want to change?" can make the conversation easier. Having little or no interest in sex doesn't necessarily require treatment simply because of societal expectations, unless the person is bothered by it. However, a significant change that causes distress is sufficient reason to seek support. You don't need to wait for a specific period of time or for the relationship to be seriously affected to ask for help.
Stress, intensive care responsibilities, sleep deprivation, depression, anxiety, relationship problems, and sexual pain are all topics addressed in the assessment. Certain chronic illnesses, medications, and hormonal changes can also affect libido. Finding a single cause is not always possible; several factors can reinforce each other. For example, the anticipation of pain can lead to avoidance of intimacy, and avoidance can lead to feeling misunderstood in the relationship. The NHS and NHS Inform recommend assessing the sources of low libido, considering both physical and emotional factors together.
Investigating the causes doesn't mean searching for a culprit. The individual's experience should be considered when discussing workload, household responsibilities, or communication style in the relationship. Statements like "It's all in your head" or "Your hormones are just low" oversimplify the situation. When preparing for the interview, it may be sufficient to note two or three aspects of daily life that challenge you the most. Keeping detailed daily records or constantly scoring sexual behaviors is not mandatory; monitoring methods that put the individual under more pressure should be avoided.
Gynecologists and family physicians are the healthcare professionals to consult for an initial assessment. A gynecological evaluation can be particularly helpful if there is pain, dryness, menstrual changes, or postpartum complaints. Depending on psychological symptoms and relationship needs, support from a psychiatrist, clinical psychologist, or a suitably trained sex therapist may be planned. Sexual therapy is a form of support that can be conducted alongside medical evaluation when necessary.
When scheduling an appointment, you don't need to explain the issue in detail over the phone; simply saying "I'd like to see a doctor about decreased sexual desire" is sufficient. It's possible to arrange a private appointment, have your partner wait outside, or postpone answering sensitive questions. Asking for clarification if you don't understand a phrase used by the healthcare professional will facilitate the assessment. If the recommended referral requires a transfer to another specialist, you can find out which question this was intended to answer and who is responsible for follow-up.
The initial assessment discusses the onset of symptoms, previous sexual experiences, pain, dryness, mood, medications, and the individual's goals. The scope of the physical examination is determined by the symptoms and is performed with informed consent. A comprehensive hormone panel is not required at every visit. If the history and findings suggest a condition such as thyroid disease, relevant tests may be selected. According to the ISSWSH guidelines, a single testosterone level does not constitute a definitive diagnosis of sexual desire disorder.
A blood test result being within the reference range does not mean the complaint is insignificant; similarly, a result outside the reference range does not explain the entire problem. When ordering the test, you can ask, "What possibility is this measurement investigating, and how will the result affect treatment?" Bringing a list of previously performed tests and medications can reduce unnecessary repetitions. If you experience pain or anxiety during the examination, you have the right to state this and request that the procedure be stopped. The assessment should proceed in a way that protects the individual's sense of security.
The treatment plan is created based on the priorities determined during the consultation. The table below is not a prescription; it shows why different complaints may require different approaches. A single individual may have more than one condition. Which step to begin with depends not only on the expected benefit but also on the individual's preferences, daily circumstances, and co-existing health problems.
| Key takeaway | The approach evaluated in the meeting |
|---|---|
| Pain or dryness | Investigating the cause and providing treatment aimed at comfort. |
| Changes after medication | Reviewing the benefits and side effects with the prescribing physician. |
| Anxiety or relationship difficulties | Individual or, where appropriate, couples-focused support. |
| Menopausal symptoms | Hormonal or non-hormonal options are available, depending on symptoms and individual risks. |
| Heavy work and fatigue | Rest, shared responsibilities, and workable lifestyle arrangements. |
None of the headings in the table alone guarantee a definitive solution. For example, reduced dryness may increase comfort, but it may not automatically resolve insecurity in the relationship. Similarly, seeking communication support does not negate the need to assess unexpressed physical pain. Writing down priorities at the beginning of treatment makes it easier to discuss which changes are meaningful in subsequent sessions. Not measuring success solely by the number of interactions ensures that the individual's own experience remains visible.
Sexual therapy sessions can address thoughts and expectations related to desire, communication, and situations that make intimacy difficult. Cognitive or behavioral approaches may be used depending on the individual's needs. The goal of therapy is not to convince the person to have a relationship. The purpose of the suggested interventions should be explained, and the individual should have a say in whether or not to implement them. The choice between individual and couples therapy is made according to personal circumstances, including safety and privacy.
Prior to the session, it is advisable to obtain information about training, professional competence, confidentiality rules, and the meeting format. Instead of focusing solely on partner satisfaction, the boundaries and needs of both individuals should be discussed. Individual support can be provided even if the partner does not wish to participate. The safety of joint sessions in relationships involving coercion, intimidation, or violence is also assessed separately. In such cases, the priority is not to increase the frequency of sessions, but to support the individual's safety and ability to make their own decisions.
Burning, stinging, or pain during intimacy can reduce desire for sexual intercourse. Lubricants can help reduce friction; vaginal moisturizers serve a different purpose. However, persistent pain should not be simply dismissed by changing products. Possibilities such as infection, skin disease, hormonal changes, and pelvic floor problems should be considered for pain during intercourse . ACOG's sexual health information states that pain is a separate area of evaluation.
The patient can describe whether the pain is felt at the vaginal entrance, deeper down, and whether it occurs with or after contact. Prolonged external genital pain may also indicate conditions like vulvodynia . Continuing intimacy despite the pain is not a treatment method. Non-penetrative forms of intimacy should only be considered if the individual desires it. Instead of trying to ignore the problem by numbing the painful area, it is more meaningful to discuss the cause and appropriate approach with a healthcare professional.
During menopause, dryness, sleep disturbances, and other symptoms can affect sexual life. When evaluating vaginal dryness in menopause, it should be explained that local and systemic treatments have different goals. Hormone therapy is not suitable for everyone; personal and family health history is taken into account. NICE NG23 states that testosterone may be considered in appropriate individuals when hormone therapy alone is insufficient for low libido associated with menopause. This does not mean that every menopausal patient should be automatically given testosterone.
During a menopause consultation, a person's priority may sometimes be improving their sleep or daily comfort before addressing sexual desire. Together, you can determine which complaint should be addressed first. It is crucial to share any prior treatment received for breast cancer or hormone-related illnesses. The RCOG's menopause information also recommends discussing options after a holistic assessment. Just because a product is described online in another country does not mean that the same product is suitable or licensed under the same conditions in Türkiye.
Testosterone is a medical option considered in select patients; it is not a general energy booster or a libido enhancer for everyone. The ISSWSH guidelines emphasize discussing the benefits and risks, monitoring, and not exceeding the physiological range, particularly in properly assessed postmenopausal low libido disorder. Follow-up may be necessary for side effects such as acne or hirsutism. The limitations of long-term safety data are also part of the decision. The product, method of use, and country-specific regulatory status should be evaluated by a physician.
When treatment is recommended, questions may arise about the intended goal, when monitoring will be necessary, and what course of action will be taken if no benefit is seen. Raising hormone levels as much as possible is not the aim of treatment. Sharing gels used by others, obtaining hormones online, or using uncontrolled mixtures are inappropriate. The possibility of pregnancy and other medications should be specifically discussed during the consultation. A detailed decision regarding testosterone should be based on medical evaluation and the individual's informed choice, not on a single laboratory result.
Sleep disruption, caregiving responsibilities, physical recovery, and hormonal changes can all affect sexual desire in the postpartum period. Vaginal dryness may also occur during breastfeeding. The presence of postpartum vaginal dryness combined with pain or decreased desire should be discussed during the evaluation. Other people's experiences do not provide a deadline for returning to sexual activity. The NHS recommends seeking help from a healthcare professional if postpartum desire does not improve to a worrying degree.
The consultation should address not only physical recovery but also the need for rest, emotional well-being, and support. It's helpful to discuss any uncertainties regarding contraception. There's no need to postpone pain or significant emotional distress by thinking, "It will pass when the baby grows." Discussing sharing care responsibilities with your partner and the time you can dedicate to yourself can be concrete topics. Re-evaluating expectations regarding intimacy should be done without creating feelings of guilt.
Some medications can affect sexual function; however, the condition being treated can also reduce libido. The relationship between the change and the initiation or dosage of medication should be explained to the doctor. Medication should not be stopped on its own. The prescribing physician can discuss appropriate options by weighing the benefits and side effects of the treatment. NHS Inform suggests reviewing medications and birth control methods used to manage low libido as possible approaches.
It's helpful to bring a list of herbal products and supplements as well as prescription medications to your appointment. Don't assume that a product marketed as "natural" won't interact with other medications. Instead of trying to see what happens after stopping a medication, ask how to make the change safely. If you're being followed by multiple doctors, it's important that they are aware of each other's recommendations. Clearly mentioning sexual side effects doesn't mean you want to abandon your current treatment; it's part of seeking a more suitable plan.
Creating space for rest, discussing the need for privacy, and reducing performance pressure on intimacy can be viable starting points. These shouldn't be seen as instructions to "try harder." For example, when dealing with heavy work and caregiving responsibilities, simply suggesting relaxation may not be enough; sharing responsibilities might be a more concrete need. If desired, a person can discuss with their partner what is relaxing or uncomfortable during a time when sexual contact is not involved.
Small, sustainable changes may be more feasible than trying to reorganize one's entire life at once. It's possible to first identify a single need, see if it's being met, and then revise the plan. The expectation that every intimacy should culminate in sexual intercourse can be discussed. If an activity suggested by someone else makes you uncomfortable, you don't have to continue it. Sexual health support should center on a person's body, preferences, and the right to have a say over their boundaries.
The duration of treatment varies depending on the underlying factors and the chosen approach. During the initial check-up, not only the level of motivation but also pain, comfort, anxiety, and the individual's self-defined goals can be discussed. Initially, it should be clarified what change is expected and when a reassessment will be necessary. The plan is reviewed if no benefit is seen or if a new side effect develops. Failure to benefit from a single method does not mean that there are no other areas where support can be sought.
You can use the contact page to schedule an appointment with Assoc. Prof. Dr. Nazlı Korkmaz. Please bring your previous test results, medication list, and any questions you would like answered to your appointment. This text does not replace a personalized diagnosis or prescription. Medical information has been obtained from ACOG, NHS, NHS Inform, RCOG, and NICE; and the ISSWSH clinical practice guideline has been used for hormone therapy.
You don't necessarily need to know a diagnosis or have chosen a treatment before your first consultation. Statements like, "I want to build intimacy but I'm hesitant because of the pain," "I want to understand the change in my desire," or "I find it difficult to discuss this with my partner," are sufficient starting points for the consultation. Clearly defining the goal makes it easier to understand which support is a priority. The person's request might simply be for information; not every counseling session has to end with a decision to start medication.
Initial goals may change during follow-up. As pain subsides, another relationship-related need may emerge, or the person's priority may become rest for a period. These changes should not be considered failures. Being able to say, "It was difficult for me to implement this suggestion," during the consultation allows for adapting the plan to real-life situations. The feasibility of the treatment should not depend solely on the individual's effort; time, cost, privacy, and support options should also be discussed. In this way, insistence on an approach that seems suitable on paper but is not sustainable in daily life is avoided.
Reading about the experiences of others facing similar issues online can help you feel less alone. However, a method that quickly benefits one person may not yield the same results for you. When considering an opinion or suggestion, it's helpful to consider who it's for, what problem it targets, and under what health conditions it's used. You can openly ask about this suggestion during your appointment. What's expected of a healthcare professional is not to judge you, but to clearly explain how the option makes sense in your situation. Communication where the individual can comfortably ask questions is a vital part of the follow-up process.
No. Physical health, medications, mental state, pain, and relationship conditions are all considered together. A single hormonal result does not explain the whole picture.
Not everyone needs the same tests. The doctor will determine which test would be useful based on the patient's history and symptoms.
Differences in desires alone do not constitute illness. Your difficulties, needs, and free choice are the determining factors in the assessment.
Yes. Individual support is available; partner participation is not mandatory in all cases.
Addressing the underlying causes of symptoms can be helpful. Outcomes vary from person to person; no guaranteed or immediate improvement can be promised.
No product is proven safe or effective simply because it is described as natural. Its ingredients, possible interactions and the person’s health need to be assessed.
The medicine may contribute to reduced desire, but you should not stop it yourself. Discuss safe options with the clinician who prescribed it.
Continuing contact despite the pain is not treatment. It is necessary to stop contact and assess the cause of the pain.